Security key
603170101
Mineralys Therapeutics, Inc. - Common Stock, par value $0.0001 per share (MLYS)
CUSIP: 603170101
Q1 2023 13F Holders as of 31 Mar 2023
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Total 13F shares
- 24,614,198
- Total 13F value
- $385,431,208
- Share change
- +24,614,198
- SEC-reported price per share
- $15.66
- Number of holders
- 66
- Value change
- +$385,431,208
- Number of buys
- 66
- Shares outstanding
- 79,235,030
Holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2023
Institutions
66
Top holders
10
MLYS full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
Mineralys Therapeutics, Inc. SEC filings
Mineralys Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 603170101
Recent filing periods:
Ownership snapshot
Top reported holders of MLYS - Mineralys Therapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
HBM Healthcare Investment...
Disclosed value leader
HBM Healthcare Investment...
Comparable rows
0/2
Latest evidence
14 Feb 2023
3/4/5
Highest disclosed value: $19,199,542
2 rows are not safely comparable across share classes.
Quick read
HBM Healthcare Investments (Cayman) Ltd. has the largest disclosed position value at $19.2M.
0 of 2 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens HBM Healthcare Investments (Cayman) Ltd.'s linked filing trail.
Disclosed position value
Top 1
HBM Healthcare Investments (Cayma...
$19.2M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-2 of 2 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| HBM Healthcare Investments (Cayman) Ltd. |
3/4/5
10%+ Owner
|
—
class O/S missing
|
$19,199,542
3,218,106 shares
|
— | 14 Feb 2023 |
| Alexander Asam |
3/4/5
Director
|
—
class O/S missing
|
—
44,000 shares
|
— | 09 Feb 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
66
Shares
24,614,198
Rows available
66
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2023 vs Q1 2023 Across Filers
Q1 2023 holders
66
Q1 2023 holders
66
Holder diff
0
| Investor | Q1 2023 Shares | Q1 2023 Shares | Share Diff | Share Chg % | Q1 2023 value | Q1 2023 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend